Option Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have received a consensus rating of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $31.25.

Several research analysts have weighed in on OPCH shares. Morgan Stanley set a $28.00 price target on shares of Option Care Health in a report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $26.00 price target on shares of Option Care Health in a report on Friday, May 1st. JPMorgan Chase & Co. lowered their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Zacks Research cut shares of Option Care Health from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Finally, Stephens set a $30.00 target price on shares of Option Care Health in a research report on Friday, May 1st.

Insiders Place Their Bets

In other Option Care Health news, CEO John Charles Rademacher bought 12,500 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the transaction, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the firm’s stock in a transaction on Monday, May 4th. The shares were acquired at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the transaction, the director owned 450,000 shares in the company, valued at approximately $9,634,500. This represents a 8.86% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 73,264 shares of company stock worth $1,548,316 in the last quarter. Corporate insiders own 1.70% of the company’s stock.

Institutional Trading of Option Care Health

Institutional investors and hedge funds have recently made changes to their positions in the company. V Square Quantitative Management LLC bought a new stake in shares of Option Care Health during the 4th quarter worth approximately $25,000. Cornerstone Planning Group LLC lifted its holdings in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. Advisory Services Network LLC bought a new stake in shares of Option Care Health during the 3rd quarter worth approximately $35,000. McIlrath & Eck LLC bought a new stake in shares of Option Care Health during the 2nd quarter worth approximately $37,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Option Care Health during the 3rd quarter worth approximately $38,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of OPCH stock opened at $20.51 on Tuesday. Option Care Health has a 52-week low of $18.01 and a 52-week high of $36.80. The stock has a market cap of $3.22 billion, a PE ratio of 15.90, a PEG ratio of 1.14 and a beta of 0.67. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The firm’s 50 day moving average price is $24.32 and its two-hundred day moving average price is $29.53.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, analysts forecast that Option Care Health will post 1.64 EPS for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.